Pamela Pavco
2016 - RXi Pharmaceuticals
In 2016, Pamela Pavco earned a total compensation of $499.5K as Chief Development Officer at RXi Pharmaceuticals, a 3% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $108,186 |
|---|---|
| Option Awards | $13,200 |
| Salary | $377,522 |
| Other | $585 |
| Total | $499,493 |
Pavco received $377.5K in salary, accounting for 76% of the total pay in 2016.
Pavco also received $108.2K in non-equity incentive plan, $13.2K in option awards and $585 in other compensation.
Rankings
In 2016, Pamela Pavco's compensation ranked 11,179th out of 14,075 executives tracked by ExecPay. In other words, Pavco earned more than 20.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,179 out of 14,075 | 21st |
Division Manufacturing | 4,338 out of 5,489 | 21st |
Major group Chemicals And Allied Products | 1,547 out of 1,895 | 18th |
Industry group Drugs | 1,248 out of 1,538 | 19th |
Industry Pharmaceutical Preparations | 972 out of 1,176 | 17th |
Source: SEC filing on April 27, 2017.
Pavco's colleagues
We found one more compensation record of an executive who worked with Pamela Pavco at RXi Pharmaceuticals in 2016.
2016
Geert Cauwenbergh
RXi Pharmaceuticals